OverviewChartNewsTraderScreen

Erste Bank Bonus Zert FACC 28.03..../  AT0000A3C937  /

Stuttgart
5/27/2024  5:00:29 PM Chg.+0.01 Bid5:30:53 PM Ask5:30:53 PM Underlying Strike price Expiration date Option type
6.91EUR +0.14% 6.90
Bid Size: 10,000		 6.98
Ask Size: 10,000		 FACC AG INH.AKT. - EUR 3/28/2025 Call
GlobeNewswire 5/17 Oragenics, Inc. to Host Webinar Panel on Neurotrauma Medicine
GlobeNewswire 5/17 Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biol...
GlobeNewswire 5/16 CVRx Announces Key Senior Leadership Team Hires
GlobeNewswire 5/15 Study Shows High Volume Exercise Unrelated to Progression of Coronary Artery Calcium
GlobeNewswire 5/15 HeartFlow's Plaque Analysis Leading The Way: 95% Accuracy vs Invasive Imaging In Newly Published REV...
GlobeNewswire 5/7 Matinas BioPharma’s LNC Platform for the Delivery of Small Oligonucleotides Featured in Two Presenta...
GlobeNewswire 5/7 Rugby Provides Exploration Update on its Gold-Silver Projects in  Santa Cruz Province, Argentina
GlobeNewswire 5/2 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stan...
GlobeNewswire 4/30 Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacem...
GlobeNewswire 4/23 Clinical ink announces GlucoseReady™
GlobeNewswire 4/8 Milestone® Pharmaceuticals Announces Etripamil Data Demonstrating Patients’ Ability to Self-Manage R...
GlobeNewswire 4/7 Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL® (...
GlobeNewswire 4/1 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and Eu...
GlobeNewswire 3/27 Renexxion Ireland Ltd. and Dr. Falk Pharma GmbH Announce FDA Clearance of the Investigational New Dr...
GlobeNewswire 3/25 Esperion Announces Data from CLEAR Outcomes Sub-Groups as Poster Presentations, Moderated Session & ...
GlobeNewswire 3/25 Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
GlobeNewswire 3/13 Wayne J. Franklin, M.D., F.A.C.C., named senior vice president of the Children’s National Heart Cent...
GlobeNewswire 3/12 HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journa...
GlobeNewswire 2/27 Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients wit...
GlobeNewswire 2/26 HeartSciences Adds Key Advisor to its Scientific Advisory Board
GlobeNewswire 2/22 RAJANT HEALTH’S CUTTING-EDGE WEARABLE RECEIVES MEDICAL EXPERT ENDORSEMENTS
GlobeNewswire 2/20 Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Hear...
GlobeNewswire 2/9 Inteleos Announces 2024 Board of Directors
GlobeNewswire 2/7 Renexxion Ireland’s European Partner, Dr. Falk Pharma GmbH, has Elected PPI-non-responsive Symptomat...
GlobeNewswire 1/29 Longeveron Receives Notice of United States Patent Allowance for the Technology Behind its Lead Inve...